Characterization and regulation of the 5′-flanking region of the murine endothelial protein C receptor gene

被引:21
作者
Gu, JM
Fukudome, K
Esmon, CT
机构
[1] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA
[2] Saga Med Sch, Dept Immunol, Saga 849, Japan
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
[5] Howard Hughes Med Inst, Oklahoma City, OK 73104 USA
关键词
D O I
10.1074/jbc.275.17.12481
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein C pathway plays a critical role in the negative regulation of blood coagulation The nucleotide sequence of the murine endothelial protein C receptor (mEPCR) gene was determined for 8.8 kilobase pairs of the genomic structure and 3.4 kilobase pairs of the 5'-flanking region. RNase protection assay revealed six major transcription start sites clustered at -100 to - 109 upstream of the translation initiation site. A series of 5'-promoter deletion fragments were fused to a luciferase reporter gene and transiently transfected into bovine aortic endothelium. Deletion of the sequence from -220 to -180 dramatically reduced luciferase expression in bovine aortic endothelial cells. This region of the murine endothelial protein C receptor gene contains one AP4 site and one SP1 site. Mutations in the core sequence of the AP4 and SP1 sites impaired both nuclear protein binding and luciferase expression. These results suggest important roles for AP4 and SP1 in the constitutive expression of mEPCR. A thrombin response element (CCCACCCC) was found to mediate the induction of mEPCR by thrombin in cell culture. Transgenic mice were developed expressing green fluorescent protein driven by the -350 to -1 or - 1080 to -1 promoter. Thrombin up-regulated mEPCR and the transgene in vivo.
引用
收藏
页码:12481 / 12488
页数:8
相关论文
共 39 条
[1]  
[Anonymous], 1998, Intensive Care Medicine
[2]   WEIGHT MATRIX DESCRIPTIONS OF 4 EUKARYOTIC RNA POLYMERASE-II PROMOTER ELEMENTS DERIVED FROM 502 UNRELATED PROMOTER SEQUENCES [J].
BUCHER, P .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 212 (04) :563-578
[3]   TUMOR NECROSIS FACTOR SUPPRESSES TRANSCRIPTION OF THE THROMBOMODULIN GENE IN ENDOTHELIAL-CELLS [J].
CONWAY, EM ;
ROSENBERG, RD .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) :5588-5592
[4]   FACS-optimized mutants of the green fluorescent protein (GFP) [J].
Cormack, BP ;
Valdivia, RH ;
Falkow, S .
GENE, 1996, 173 (01) :33-38
[5]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[6]   TREATMENT OF HOMOZYGOUS PROTEIN-C DEFICIENCY AND NEONATAL PURPURA FULMINANS WITH A PURIFIED PROTEIN-C CONCENTRATE [J].
DREYFUS, M ;
MAGNY, JF ;
BRIDEY, F ;
SCHWARZ, HP ;
PLANCHE, C ;
DEHAN, M ;
TCHERNIA, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (22) :1565-1568
[7]   PERMANENT CELL-LINE EXPRESSING HUMAN FACTOR-VIII-RELATED ANTIGEN ESTABLISHED BY HYBRIDIZATION [J].
EDGELL, CJ ;
MCDONALD, CC ;
GRAHAM, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3734-3737
[8]   AN UPDATE ON CLINICAL AND BASIC ASPECTS OF THE PROTEIN-C ANTICOAGULANT PATHWAY [J].
ESMON, CT ;
SCHWARZ, HP .
TRENDS IN CARDIOVASCULAR MEDICINE, 1995, 5 (04) :141-148
[9]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743
[10]   Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor [J].
Fukudome, K ;
Ye, XF ;
Tsuneyoshi, N ;
Tokunaga, O ;
Sugawara, K ;
Mizokami, H ;
Kimoto, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07) :1029-1035